Cargando…
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration
OBJECTIVES: This report aims to provide clear recommendations and practical guidance from a panel of UK retinal experts on an aflibercept treat-and-extend (T&E) pathway that can be implemented in clinical practice. These recommendations may help service providers across the NHS intending to impl...
Autores principales: | Ross, Adam H., Downey, Louise, Devonport, Helen, Gale, Richard P., Kotagiri, Ajay, Mahmood, Sajjad, Mehta, Hemal, Narendran, Niro, Patel, Praveen J., Parmar, Nina, Jain, Nitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608090/ https://www.ncbi.nlm.nih.gov/pubmed/31900438 http://dx.doi.org/10.1038/s41433-019-0747-x |
Ejemplares similares
-
Practical implementation of a q4–q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panel
por: Bailey, Clare, et al.
Publicado: (2022) -
Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
por: Patel, Praveen J, et al.
Publicado: (2017) -
Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service
por: Gale, Richard P., et al.
Publicado: (2019) -
Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
por: McKibbin, M, et al.
Publicado: (2015) -
Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA
por: Yang, Yit, et al.
Publicado: (2017)